Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1997-7-17
|
pubmed:abstractText |
A 42-year-old man developed mixed cryoglobulinemia secondary to hepatitis C virus (HCV) infection with hypocomplementemia and nephrotic syndrome. His renal biopsy showed membranoproliferative glomerulonephritis type I (MPGN). Despite treatment with interferon-alpha, three million units three times a week for a total of 6 months, the patient continued to have hypocomplementemia, cryoglobulinemia, and nephrosis. After a course of high-dose interferon-alpha treatment consisting of ten million units daily for 2 weeks followed by 10 million units three times per week for an additional 6 weeks, HCV RNA and cryoglobulin testing became negative, complement levels increased to normal levels, and nephrotic syndrome remitted. This case confirms an association between HCV infection and MPGN and suggests a role for high-dose interferon-alpha treatment when conventional interferon therapy fails.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0272-6386
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
113-5
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9214409-Adult,
pubmed-meshheading:9214409-Antiviral Agents,
pubmed-meshheading:9214409-Cryoglobulinemia,
pubmed-meshheading:9214409-Drug Administration Schedule,
pubmed-meshheading:9214409-Glomerulonephritis, Membranoproliferative,
pubmed-meshheading:9214409-Hepatitis C,
pubmed-meshheading:9214409-Humans,
pubmed-meshheading:9214409-Interferon-alpha,
pubmed-meshheading:9214409-Male
|
pubmed:year |
1997
|
pubmed:articleTitle |
Response to high-dose interferon-alpha after failure of standard therapy in MPGN associated with hepatitis C virus infection.
|
pubmed:affiliation |
Department of Pathology, University of Pittsburgh Medical Center, PA 15213-2500, USA.
|
pubmed:publicationType |
Journal Article,
Case Reports
|